Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1-Reference-Cited by-同舟云学术

Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1

Published:2016-07 Issue: Volume:56 Page:S59-S72
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Vaidyanathan Jayabharathi¹,Yoshida Kenta¹²,Arya Vikram¹,Zhang Lei¹

Affiliation:

1. Office of Clinical Pharmacology, Office of Translational Sciences; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MD

2. Oak Ridge Institution for Science and Education (ORISE) Fellow

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Transporter-mediated drug interactions: clinical implications and in vitro assessment;Lin;Expert Opin Drug Metab Toxicol,2007

2. Transporter-mediated drug-drug interactions;Muller;Pharmacogenomics,2011

3. The role of transporters in drug interactions;Endres;Eur J Pharm Sci,2006

4. Membrane transporters in drug development;Giacomini;Nat Rev Drug Discov.,2010

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membrane transporters in drug development and as determinants of precision medicine;Nature Reviews Drug Discovery;2024-01-24

2. Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins;Pharmaceutics;2023-12-31

3. Advances in the Evaluation of Gastrointestinal Absorption Considering the Mucus Layer;Pharmaceutics;2023-11-30

4. Utilization of OATP1B Biomarker Coproporphyrin‐I to Guide Drug–Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry;Clinical Pharmacology & Therapeutics;2023-10-11

5. Regulatory Considerations in Metabolism‐ and Transport‐Based Drug Interactions;Oral Bioavailability and Drug Delivery;2023-10-10